DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 129 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is 2.14 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMERICA BANK | 206 | $2,527 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 117,576 | $1,442,657 | 0.00% |
| Invesco Ltd. | 19,162 | $235,118 | 0.00% |
| Avion Wealth | 37 | $0 | 0.00% |
| ALLIANCEBERNSTEIN L.P. | 35,070 | $430,309 | 0.00% |
| UBS Group AG | 23,881 | $293,020 | 0.00% |
| Walleye Trading LLC | 14,966 | $183,633 | 0.00% |
| Citadel Advisors | 16,900 | $207,363 | 0.00% |
| Citadel Advisors | 15,500 | $190,185 | 0.00% |
| Citadel Advisors | 6,754 | $82,871 | 0.00% |
| NOMURA ASSET MANAGEMENT CO LTD | 0 | $0 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 20,600 | $252,762 | 0.00% |
External links
This page lists DAY ONE BIOPHARMACEUTICALS I's shareholders in Q3 2023. To view DAY ONE BIOPHARMACEUTICALS I's shareholder history, click here.